Whoop is thrilled to be in partnership with Battle Cancer in 2022, across the Battle Cancer Program and Events. Our hope is that WHOOP will add to the great work being done by the Battle Cancer team, providing key data, research and support to all involved.
Briain Curtin, International Marketing Director at WHOOP
EXCLUSIVE DISCOUNT ON A WHOOP MEMBERSHIP
SAVE WHILE SUPPORTING PEOPLE POST-CANCER
WHOOP is offering Battle Cancer athletes an exclusive £30/$30/€30 discount on a WHOOP membership AS WELL as making a $50 donation to The Battle Cancer Program from every sale.
When you sign up for a WHOOP membership you'll be directly supporting cancer survivors by helping us pay for fully-funded programs in gyms local to them.
SUPPORTING FITNESS POST-CANCER
We have joined forces with WHOOP with the goal to help eradicate medical and fitness stigmas around exercise post-cancer through The Battle Cancer Program – our charity arm which offers fully-funded, 12-week programs for people who have completed treatment for cancer.
We're integrating WHOOP™ wearable technology for all participants to deliver data-driven interventions to support individually optimised programming results.
HOW WILL WHOOP HELP?
Participants that opt-in will have the opportunity to wear a WHOOP 4.0, a wearable device that monitors sleep, recovery and daily effort around the clock, during the entirety of the training cycle, offering real-time, quantitative personalised data.
This will allow participants to avoid second-guessing how they feel and encourage them to train if their recovery score, calculated from the previous 24 hours data including HRV, resting heart rate and sleep performance, is satisfactory.
"Working with WHOOP gives us invaluable insight to monitoring those changes that matter most. Our programming is all about making meaningful changes that will enhance and galvanise people's health and fitness. By equipping our clients and coaches with WHOOP technology we will be able to track those changes that shape the futures of the people we support."
Dr Colin Robertson, Director of Science and Research at The Battle Cancer Program